<DOC>
	<DOCNO>NCT02048930</DOCNO>
	<brief_summary>The aim study compare clinical effectiveness cost-effectiveness Easyhaler® ( EH ) device DPI device commonly use UK UK primary care asthma population patient age 6 80 year .</brief_summary>
	<brief_title>Real Life Effectiveness Easyhaler ( Orion )</brief_title>
	<detailed_description>A recent observational study Price et al carry use UK 's General Practice Research Database ( CPRD ) compare asthma-related outcome different inhale corticosteroid ( ICS ) inhaler device , use Easyhaler dry powder inhaler ( DPIs ) .</detailed_description>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients must also meet follow inclusion criterion : ( 1 ) Aged : 680 year stratify 611 year ; 1260 year ; ≥61 year allow paediatrics adolescent / adult sub analyse ; allow exclusion elderly ( age 61+ ) smoker exsmokers require . ( 2 ) Ongoing asthma therapy : ≥2 prescription asthma outcome period ( i.e . ≥1 prescription ( asthma therapy ) addition prescription ICS IPD ( initiation / stepup/ switch ) . ( 3 ) Evidence active asthma : 1 . Initiation diagnostic code asthma 2 . Stepup / Switch ≥2 prescription asthma ( least one ICS ) different point time baseline year PLUS diagnostic code asthma . ( 4 ) Have least one year uptostandard ( UTS ) baseline data least one year UTS outcome data ( follow IPD ) . Patients exclude analysis : ( 1 ) Had COPD read code time ; and/or ( 2 ) Had chronic respiratory disease , except asthma , time ; and/or ( 3 ) Patients maintenance oral steroid baseline year ; and/or ( 4 ) Multiple ICS prescription IPD .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>GPRD</keyword>
	<keyword>effectiveness</keyword>
	<keyword>cost-effectiveness</keyword>
	<keyword>Easyhaler</keyword>
	<keyword>Primary care</keyword>
	<keyword>DPI</keyword>
</DOC>